Literature DB >> 1391186

Relationship between pulmonary arterial pressure and lesions in the pulmonary arteries and parenchyma, and cardiac valves in canine dirofilariasis.

Y Sasaki1, H Kitagawa, Y Hirano.   

Abstract

The relationship between pulmonary hypertension and lesions was examined in 41 dogs infested naturally with heartworms, which consisted of 28 cases with pulmonary heartworm disease and 13 cases with caval syndrome. Pulmonary arterial pressure (PAP) was measured before and 1 or 7 days after heartworm removal with a flexible alligator forceps. In these dogs, lesions were examined after the last measurement of PAP. The mean PAP was 28.2 +/- 16.0 mmHg (10.9 to 81.4 mmHg in range) at post-removal phase. Pulmonary arterial intimal lesions, pulmonary thromboemboli, pneumonic lesions, tricuspid valvular lesions and mitral valvular lesions were macroscopically recognized in 95, 59, 39, 54 and 56% of cases, respectively. These lesions were classified by severity and the relationship with PAP was examined by the multiple correlation analysis. The multiple coefficient correlation was found the highest between PAP and thromboemboli, followed by mitral valvular lesion, tricuspid valvular lesion, and pneumonic lesion. There was no significant correlation between PAP and intimal lesions. The coefficient of determination showed the highest value in thromboemboli when one variable was used, and increased only very slightly when a variable of thromboemboli was added to those of other lesions. The cases with high PAP had fresh thromboemboli in large pulmonary arteries. From these evidences, it was concluded that thromboemboli following natural death of heartworm was the most important factor causing an increase in PAP and developing clinical signs in canine heartworm disease.

Entities:  

Mesh:

Year:  1992        PMID: 1391186     DOI: 10.1292/jvms.54.739

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

Review 1.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

2.  Doppler echocardiographic evidence of pulmonary hypertension in dogs: a retrospective clinical investigation.

Authors:  P Paradies; P P Spagnolo; M E Amato; D Pulpito; M Sasanelli
Journal:  Vet Res Commun       Date:  2014-01-11       Impact factor: 2.459

3.  Pre- and post-operative cardiac evaluation of dogs undergoing lobectomy and pneumonectomy.

Authors:  Meriç Kocatürk; Hakan Salci; Zeki Yilmaz; A Sami Bayram; Jørgen Koch
Journal:  J Vet Sci       Date:  2010-09       Impact factor: 1.672

4.  Pulmonary arterial remodeling induced by a Th2 immune response.

Authors:  Eleen Daley; Claire Emson; Christophe Guignabert; Rene de Waal Malefyt; Jennifer Louten; Viswanath P Kurup; Cory Hogaboam; Laimute Taraseviciene-Stewart; Norbert F Voelkel; Marlene Rabinovitch; Ekkehard Grunig; Gabriele Grunig
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

5.  ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.

Authors:  Carol Reinero; Lance C Visser; Heidi B Kellihan; Isabelle Masseau; Elizabeth Rozanski; Cécile Clercx; Kurt Williams; Jonathan Abbott; Michele Borgarelli; Brian A Scansen
Journal:  J Vet Intern Med       Date:  2020-02-17       Impact factor: 3.333

6.  Spontaneous tricuspid valve chordal rupture in a dog with severe, irreversible pulmonary hypertension caused by Angiostrongylus vasorum infection.

Authors:  Viktor Szatmári
Journal:  BMC Vet Res       Date:  2020-08-26       Impact factor: 2.741

7.  Intracardiac heartworms in dogs: Clinical and echocardiographic characteristics in 72 cases (2010-2019).

Authors:  Abigail E Romano; Ashley B Saunders; Sonya G Gordon; Sonya Wesselowski
Journal:  J Vet Intern Med       Date:  2020-12-06       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.